Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Camptothecin: Potential Cancer Treatment Found In Assam

DAIKENCHUTO: A JAPANESE HERBAL MEDICATION METHOD

Zoonotic illness: Transmission between man and animal

Camptothecin: Potential Cancer Treatment Found In Assam
  • BiotechToday
  • World

Camptothecin: Potential Cancer Treatment Found In Assam

bioxone March 24, 2021March 24, 2021

Thota Kanishka Rao, Amity University Kolkata

Cancer is the second leading cause of death worldwide and is responsible for causing nearly 10 million deaths per annum. The significant reason cancer being so lethal is due to the absence of anti-cancer treatments. Though, very recently researchers have discovered a new plant species having the potential to aid in fighting cancer.

The species named Ophiorrhiza recurvipetala has been discovered in the central district of Assam and classified under the Rubiaceae family of flowering plants, to which the plant yielding coffee belongs. All the members of this group consist of a secondary metabolite known as Camptothecin utilized in colon cancer.

Ophiorrhiza is a primarily herbaceous class found from eastern India toward the West Pacific from South China to northern Australia. As per the World Checklist of Selected Plant Families, 2017, it is a remarkably species-rich and systematically convoluted sort with around 318 species around the world. 

In India, 47 species and 9 varieties have been found. The Ophiorrhiza recurvipetala is an enduring spice with a height of 60 cm and is branched. It yields a creamy white flower.

Researchers have reported that these species are restricted to growing in moist and shady places only. It would require more scientific study and experimentation to see if the Camptothecin content occurring in this novel species would be useful to treat cancer or not.

Also read:DAIKENCHUTO: A JAPANESE HERBAL MEDICATION METHOD

Source: https://www.thehindu.com/news/national/new-assam-plant-species-may-aid-anti-cancer-battle/article34103961.ece

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged anti-cancer Assam Camptothecin cancer Ophiorrhiza recurvipetala Rubiaceae family treatment

One thought on “Camptothecin: Potential Cancer Treatment Found In Assam”

  1. Pingback: Zoonotic illness: Transmission between man and animal - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Zoonotic illness: Transmission between man and animal

bioxone March 25, 2021

Rohit Bhattacharjee, Amity University, Kolkata Zoonotic illnesses are those contaminations that can pass between species from animals to mankind, just as from mankind to animals. Most (60.3 percent) arising infections influencing people had an animal source and most of these (71.8 percent) came from natural life, as per a recent report.  While COVID-19’s unique leap […]

Zoonotic

Related Post

  • Latest
  • World

Do dreams have any relation with neurological disorders?

bioxone September 19, 2020September 19, 2020

-Anuska Sen, Team bioXone The word “dreams” is quite a commonly used one. There are indeed numerous cultural, religious, and historical explanations regarding the occurrence of dreams. But the exact underlying scientific purpose and mechanism of dreams have not yet been understood. This has led to years of intensive research in oneirology (the scientific study […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

D614G: NEW CORONAVIRUS MUTATIONS MAKES THE VIRUS EIGHT TIMES MORE INFECTIOUS

bioxone February 19, 2021February 19, 2021

Aishila Kar, Amity University Kolkata The research, confirms findings that D614G — one of many mutations in the concerning variants that have emerged in the UK, South Africa, and Brazil — makes the coronavirus 8times more infectious. This novel coronavirus, D614G mutation in the spike protein renders it up to 8 times more infectious in […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India
  • World

AstraZeneca: Late-stage trial of Covid-19 antibody medicine to start soon

bioxone October 12, 2020October 12, 2020

Prama Ghosh, Amity University Kolkata After the recovery of President Donald Trump from Covid-19 using a similar therapy as of the antibody medicine from AstraZeneca Plc, the company has started its late-stage trials for the same against COVID-19. The medicine will undergo two trials on more than 60000 people starting soon. Astra has also planned […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy